Dimerisiertes Peptid

Patent europeic · EP2154145 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2154145
Numer da la dumonda
EP09172205
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
15-01-2004
Publitgà
17-02-2010
Concedì
24-04-2013
Stritgà
31-01-2014
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 7/06 (2006.01)
C07K 7/08 (2006.01)
C07K 14/82 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
A61P 37/04 (2006.01)
C07K 14/705 (2006.01)
Prioritad
JP 2003007122 15.01.2003
Derivà da
EP04702444
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-08-2014

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.08.2014

  2. 24-04-2013

    Concedì

    Published in Swissreg on 24.04.2013

Partidas

Possessur

International Institute of Cancer Immunology, Inc.

13-9, Enoki-cho, Suita-shi, Osaka-fu, JP

CHUGAI SEIYAKU KABUSHIKI KAISHA

Chugai Seiyaku Kabushiki Kaisha

5-1 Ukima 5-chome, Kita-ku Tokyo 115-8543, JP

Dainippon Sumitomo Pharma Co., Ltd.

6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi, Osaka-fu, JP

Inventur

Takasu, Hideo

Nishinomiya-shi, Hyogo 662-0084, JP

Samizo, Fumio

Suita-shi, Osaka 565-0854, JP

Sugiyama, Haruo

Minoo-shi, Osaka 562-0036, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.